AKT1 and glioblastoma: In addition, the signals transduction pathways (such as p53, phosphatidylinositol-3 kinase/Akt, and Ras/MEK/ERK) downstream these receptors are altered, leading to aberrant proliferation and invasiveness of GBM cells [4].